Abstract-A short overview is given of new developments in the chemo-enzymatic synthesis of amino acids. Amino acid resolution procedures based on stereoselective enzymatic hydrolysis of amino acid amides have been developed. Two enzymes, an aminopeptidase from P s e u d o m o n a s p u t i d a and an amidase from H y c o b a c t e r i u m n e o a u r u m have been purified to homogeneity. In addition, methods for the stereoselective synthesis of a-alkyl-substituted hydroxy acids are given.
INTRODUCTION
Amino acids and derivatives are becoming increasingly important as intermediates for pharmaceuticals and agro-chemicals. Well-known examples include D-phenylglycine and D-p-hydroxy-phenylglycine as building blocks for the antibiotics Ampicillin respectively Amoxycillin and L-phenylalanine for the dipeptide sweetener Aspartame. More recently, L-homophenylalanine and derivatives are used for the synthesis of ACE-inhibitors, L-valine as a precursor for the immuno-depressant Cyclosporin A and D-valine in the production of Fluvalinate, a pyrethroid insecticide.
At DSM a generally applicable resolution process based on the enzymatic hydrolysis of amino acid amides with an aminopeptidase from P s e u d o m o n a s p u t i d a has been developed. The principle step of the process is depicted in scheme 1 ( R 2 = H). Also visualized in this scheme is the resolution of a-disubstituted amino acids (R2= alkyl) with the aid of an L-amidase preparation from H y c o b a c t e r i u m neoaurum. Both processes have been extensively reviewed (ref.1). Recent developments include new approaches towards the synthesis of the starting materials of the enzymic resolution (a-H and a-alkylsubstituted amino acid amides), enzyme purification and the development of other aminopeptidase or amidase preparations with different substrate and/or stereoselectivities. Some of these developments will be discussed in the sequel. Moreover, some applications of the amino acid derivatives will be given. Finally, the enzymatic resolution of a-H and a-alkyl substituted hydroxy-acids will be discussed. L-Lupinic acid is an isolate from lupinus angustifolins and is a principal metabolite of the phytohormone trans-zeatin, being one of the most effective natural stimulants of plant cell division.
a-Alkylsubstituted amino acids
A well-known application of the use of a-alkylsubstituted amino acids in the pharmaceutical industry is L-a-methyl-3,4-dihydroxyphenylalanine, which is used as a drug to treat patients suffering from high blood pressure. More recently, medicinal chemists have become interested in bio-active peptides containing a-substituted amino acids, since they tend to freeze specific conformations and dramatically slow down enzymatic processes. Thus, the rational design of conformationally constrained compounds which mimic or block the biological effects of physiologically important peptides represents a major goal of modern medicinal chemistry. These conformational analogues should not only retain the pharmacological properties of the parent peptide, they should also exhibit improved bioavailability and pharmacokinetics. In the last decades it has been shown that Ca-methy1,Ca-alkyl-glycyl residues represent an interesting new type of conformational constraint in peptides. Thus, peptides rich in the achiral Ca,a-dimethylglycine (Aib) residue strongly prefer regularly folded backbone conformations.
More recently, the prototype of chiral a-amino acids of this family, Ca-methy1,Ca-ethylglycine, has been examined and its conformational behaviour found close to that of Aib, including an unexpected screw-sense indifference (ref. is a recently discovered aspartame derivative which is very stable at high pH values (pH 6-8). In contrast, the corresponding N-formyl ( R l = CHO) and N-carbamoyl ( R 1 = CO-NH2) derivatives of both aspartame and the (aMe)Phe analogue of aspartame were not sweet.
L-(a-Me)Phe aspartame analogues R1 9 -C-NH? 0
Rt a-Hydroxy acids
The use of homophenylalanine as a building block for the synthesis of Angiotensin-Converting-Enzyme (ACE-)inhibitors like Enalapril has been well-established. However, not only this amino acid is a good starting material for these products, also other related compounds can be used (ref. 8) . Some examples are depicted in scheme 3 .
From this scheme it is evident that also a-hydroxy acids can be versatile intermediates in the synthesis of ACE-inhibitors or other interesting pharmaceuticals. Therefore, we embarked on a program for the asymmetric synthesis and/or kinetic resolution of both a-H and a-substituted hydroxy acids.
Thus, we have found that the lipase from Pseudomonas fluorescens can be used for the kinetic resolution of a-hydroxy acid ethyl esters. Whereas, enzyme-catalyzed hydrolysis of ethyl (R,S)-2-hydroxy-2-phenylacetate was found to proceed without any stereoselectivity, ethyl (R)-2-hydroxyhexanoate and ethyl (R)-2-hydroxy-4-phenyl-butanoate could be obtained in high enantiomeric excess from the corresponding racemic esters (ref. 9).
For the synthesis of a-alkyl substituted hydroxy acids two approaches have been developed in cooperation with Prof. Kellogg at the University of Groningen. The first one was based on the transition metal catalyzed allylation of mandelic and lactic acid derivatives (scheme 4 ) .
Although a catalytic process could be developed for the synthesis of racemic material, the asymmetric catalyzed variant, however, did not lead to optically pure products. The enantiomeric excess did not exceed 30% (ref. 10). We then turned our attention to the use of an enzymatic kinetic resolution procedure. Although conceptually less elegant (the unwanted isomer can not be racemized) this approach has led to the development of a procedure for the relatively facile synthesis of multigram quantities of a number of optically pure a-substituted hydroxy acids using pig liver esterase. Moreover, in some cases both enantiomers could be obtained optically pure using a simple recrystallisation as the final purification step (ref.11). In scheme 5 some examples are given.
CONCLUSION
In conclusion it can be stated that very efficient procedures have been developed for the synthesis of optically pure unusual (and unnatural) amino acids. Both enantiomers of a-H and a-substituted amino acids can be obtained. These amino acids can be incorporated in a number of compounds with interesting conformational and physiological properties. '/os.e.(cy)acic 22(26) 51 (41) 94 (29) 75 (38) 38 (43) 80 (39) 12 (30) 40 (47) 49 (52) 64 (53) 40 (41) 86 (44) lO ( 
